![Albert H. Owens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Dr. Albert H.
Owens, Jr. MD, is President & Chief Executive Officer at FASgen LLC and President at The Johns Hopkins Hospital.
Dr. Owens was previously employed as President by FASgen, Inc.
Eerdere bekende functies van Albert H. Owens
| Bedrijven | Functie | Einde |
|---|---|---|
FASgen, Inc.
 FASgen, Inc. Pharmaceuticals: MajorHealth Technology Develops novel molecule therapeutics | President | 19-06-2012 |
The Johns Hopkins Hospital, Inc.
 The Johns Hopkins Hospital, Inc. Hospital/Nursing ManagementHealth Services Operates as a community hospital | President | - |
FASgen LLC
 FASgen LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics and diagnostics based on the selective inhibition of fatty acid biosynthesis | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
The Johns Hopkins Hospital, Inc.
The Johns Hopkins Hospital, Inc. Hospital/Nursing ManagementHealth Services Operates as a community hospital | Health Services |
FASgen, Inc.
FASgen, Inc. Pharmaceuticals: MajorHealth Technology Develops novel molecule therapeutics | Health Technology |
FASgen LLC
FASgen LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics and diagnostics based on the selective inhibition of fatty acid biosynthesis | Health Technology |
